Literature DB >> 15981047

The evolving role of endoscopic treatment for bleeding esophageal varices.

J E J Krige1, J M Shaw, P C Bornman.   

Abstract

The treatment of acute and recurrent variceal bleeding is best accomplished by a skilled, knowledgeable, and well-equipped team using a multidisciplinary integrated approach. Optimal management should provide the full spectrum of treatment options including pharmacologic therapy, endoscopic treatment, interventional radiologic procedures, surgical shunts, and liver transplantation. Endoscopic therapy with either band ligation or injection sclerotherapy is an integral component of the management of acute variceal bleeding and of the long-term treatment of patients after a variceal bleed. Variceal eradication with endoscopic ligation requires fewer endoscopic treatment sessions and causes substantially less esophageal complications than does injection sclerotherapy. Although the incidence of early gastrointestinal rebleeding is reduced by endoscopic ligation in most studies, there is no overall survival benefit relative to injection sclerotherapy. Simultaneous combined ligation and sclerotherapy confers no advantage over ligation alone. A sequential staged approach with initial endoscopic ligation followed by sclerotherapy when varices are small may prove to be the optimal method of reducing variceal recurrence. Overall, current data demonstrate clear advantages for using ligation in preference to sclerotherapy. Ligation should therefore be considered the endoscopic treatment of choice in the treatment of esophageal varices.

Entities:  

Mesh:

Year:  2005        PMID: 15981047     DOI: 10.1007/s00268-005-0138-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  66 in total

1.  Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study.

Authors:  M Umehara; M Onda; T Tajiri; M Toba; H Yoshida; K Yamashita
Journal:  Gastrointest Endosc       Date:  1999-07       Impact factor: 9.427

2.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

Authors:  G V Papatheodoridis; J Goulis; G Leandro; D Patch; A K Burroughs
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

3.  Variceal band ligation and variceal band ligation plus sclerotherapy in the prevention of recurrent variceal bleeding in cirrhotic patients: a randomized, prospective and controlled trial.

Authors:  J Argonz; D Kravetz; A Suarez; G Romero; M Bildozola; M Passamonti; J Valero; R Terg
Journal:  Gastrointest Endosc       Date:  2000-02       Impact factor: 9.427

Review 4.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

5.  Treatment of esophageal varices by injection of a sclerosing solution.

Authors:  H J MOERSCH
Journal:  J Am Med Assoc       Date:  1947-11-22

6.  A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.

Authors:  G W Johnston; H W Rodgers
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

Review 7.  Endoscopic band ligation of oesophageal varices.

Authors:  I S Tait; J E Krige; J Terblanche
Journal:  Br J Surg       Date:  1999-04       Impact factor: 6.939

Review 8.  Endoscopic sclerotherapy.

Authors:  J Terblanche; J E Krige; P C Bornman
Journal:  Surg Clin North Am       Date:  1990-04       Impact factor: 2.741

Review 9.  Prevention of variceal rebleeding.

Authors:  Jaume Bosch; Juan Carlos García-Pagán
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

10.  Endoscopic elastic band ligation for active variceal hemorrhage.

Authors:  G V Stiegmann; J S Goff; J H Sun; S Wilborn
Journal:  Am Surg       Date:  1989-02       Impact factor: 0.688

View more
  14 in total

Review 1.  Evolution of endoscopic therapy for esophageal varices.

Authors:  G V Stiegmann
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

2.  Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.

Authors:  Jake E J Krige; Urda K Kotze; Philippus C Bornman; John M Shaw; Michael Klipin
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

3.  Management of Esophageal Varices.

Authors:  James F Trotter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-07

4.  Alcoholic versus nonalcoholic cirrhosis in a randomized controlled trial of emergency therapy of bleeding varices.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Kevin S Haynes; Horacio Jinich-Brook; Roderick Rapier; Florin Vaida; Robert J Hye; Susan L Orloff
Journal:  J Surg Res       Date:  2010-12-03       Impact factor: 2.192

5.  Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis.

Authors:  M J Orloff; J I Isenberg; H O Wheeler; K S Haynes; H Jinich-Brook; R Rapier; F Vaida; R J Hye; S L Orloff
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

6.  A novel canine model of esophageal varices with a balloon dilatation constrictor.

Authors:  He-Ping Fang; Mei-Hai Deng; Nan Lin; Wei-Dong Pan; Bo Liu; Yun-Biao Lin; Zhao-Feng Tang; Rui-Yun Xu
Journal:  Dig Dis Sci       Date:  2008-10-29       Impact factor: 3.199

7.  Doppler ultrasound could predict varices progression and rebleeding after portal hypertension surgery: lessons from 146 EGDS and 10 years of follow-up.

Authors:  Fabio Gonçalves Ferreira; Maurício Alves Ribeiro; Maria de Fátima Santos; José César Assef; Luiz Arnaldo Szutan
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

8.  Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis.

Authors:  Jake E J Krige; Urda K Kotze; Greg Distiller; John M Shaw; Philippus C Bornman
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

9.  Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.

Authors:  Tammy Tursi
Journal:  J Am Acad Nurse Pract       Date:  2010-11-09

10.  Portal vein thrombosis; risk factors, clinical presentation and treatment.

Authors:  Kirstine K Sogaard; Lone B Astrup; Hendrik Vilstrup; Henning Gronbaek
Journal:  BMC Gastroenterol       Date:  2007-08-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.